Multiple Sclerosis: all 3,524 studies

Page 9 of 36. Open to participants first (668), then studies with results posted, then the rest; newest registration first within each.

• Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple SclerosisCompletedNCT03396822Results posted
• Videofluoroscopic Swallowing Study (VFSS)TerminatedNCT03387267Not applicableResults posted
• A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)TerminatedNCT03387046Phase 2Results posted
• Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)CompletedNCT03369665Phase 4Results posted
• A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTTerminatedNCT03368664Phase 3Results posted
• Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)CompletedNCT03364036Phase 4Results posted
• Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisCompletedNCT03355365Phase 2Results posted
• Mechanism of Action of Ocrelizumab in Multiple SclerosisCompletedNCT03344094Results posted
• Maximizing Outcome of Multiple Sclerosis TransplantationTerminatedNCT03342638Phase 3Results posted
• A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MSCompletedNCT03319732Phase 3Results posted
• A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MSCompletedNCT03290131Phase 3Results posted
• Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )CompletedNCT03277261Phase 3Results posted
• Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)CompletedNCT03277248Phase 3Results posted
• A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg FingolimodCompletedNCT03257358Phase 4Results posted
• Telephone-Delivered Exercise for Multiple Sclerosis FatigueCompletedNCT03256851Not applicableResults posted
• Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label OfatumumabCompletedNCT03249714Phase 2Results posted
• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisCompletedNCT03232073Phase 3Results posted
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)TerminatedNCT03222973Phase 2Results posted
• Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple SclerosisTerminatedNCT03219073Not applicableResults posted
• Computer Assisted Cognitive Rehabilitation for Persons With Multiple SclerosisCompletedNCT03200899Not applicableResults posted
• COMparison Between All immunoTherapies for Multiple Sclerosis.CompletedNCT03193866Results posted
• Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple SclerosisCompletedNCT03185065Phase 3Results posted
• Fecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsTerminatedNCT03183869Phase 2Results posted
• Evaluation of a Spasticity Management Program for People With Multiple SclerosisCompletedNCT03166930Not applicableResults posted
• Lipoic Acid for Progressive Multiple Sclerosis (MS)CompletedNCT03161028Phase 2Results posted
• Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to OcrelizumabCompletedNCT03157830Results posted
• Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT03135249Phase 4Results posted
• Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)TerminatedNCT03126760Phase 4Results posted
• Tele-Exercise and Multiple SclerosisCompletedNCT03117881Not applicableResults posted
• A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and InsomniaCompletedNCT03110315Phase 4Results posted
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2CompletedNCT03093324Phase 3Results posted
• Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)CompletedNCT03091400Phase 2Results posted
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT03085810Phase 3Results posted
• Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)CompletedNCT03073603Phase 4Results posted
• Light Therapy as Treatment for Fatigue in Multiple SclerosisCompletedNCT03060759Not applicableResults posted
• Aspirin as a Pre-Treatment for Exercise in Multiple SclerosisCompletedNCT03051646Early Phase 1Results posted
• Cognitive Remediation Augmented With Transcranial Direct Current Stimulation (tDCS)TerminatedNCT03049969Not applicableResults posted
• Natalizumab in Preventing Post-partum Relapses in Multiple SclerosisCompletedNCT03046251Phase 4Results posted
• Central Nervous System Changes Following OnabotulinumtoxinA Injection in the BladderCompletedNCT03033355Results posted
• Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS RelapsesTerminatedNCT03021317Phase 4Results posted
• Intranasal Insulin for Improving Cognitive Function in Multiple SclerosisCompletedNCT02988401Phase 1/2Results posted
• Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?CompletedNCT02987621Not applicableResults posted
• Safety of Switching From Rituximab to Ocrelizumab in MS PatientsCompletedNCT02980042Phase 3Results posted
• A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple SclerosisTerminatedNCT02975349Phase 2Results posted
• MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)TerminatedNCT02949908Results posted
• Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis PatientsCompletedNCT02939079Phase 2/3Results posted
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)TerminatedNCT02936037Phase 3Results posted
• Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)TerminatedNCT02907177Phase 3Results posted
• Medical Marijuana and Its Effects on Motor Function in People With Multiple SclerosisCompletedNCT02898974Results posted
• Efficacy and Safety of Daclizumab in Participants With RRMS Switching From NatalizumabTerminatedNCT02881567Phase 3Results posted
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)CompletedNCT02861014Phase 3Results posted
• A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS)CompletedNCT02846558Not applicableResults posted
• Integrating Caregiver Support Into MS CareCompletedNCT02835677Not applicableResults posted
• e-Mobile Tablet for People With Chronic ConditionsCompletedNCT02833311Not applicableResults posted
• Treatment of Sleep-disordered Breathing in Patients With SCICompletedNCT02830074Not applicableResults posted
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.CompletedNCT02792231Phase 3Results posted
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple SclerosisCompletedNCT02792218Phase 3Results posted
• Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary DefectCompletedNCT02772666Not applicableResults posted
• Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance ImagingCompletedNCT02767609Not applicableResults posted
• Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding StudyCompletedNCT02760056Phase 1Results posted
• Pilot Study of Transcranial Direct Current Stimulation (tDCS)CompletedNCT02746705Not applicableResults posted
• Long-Term Effects of Torso-WeightingCompletedNCT02743312Not applicableResults posted
• Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS)CompletedNCT02739542Phase 4Results posted
• Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple SclerosisCompletedNCT02738775Phase 2Results posted
• Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple SclerosisCompletedNCT02727907Phase 2/3Results posted
• Follow up Study of Patients on Fingolimod Who Were Enrolled in the Original Biobank Study (CFTY720DDE01)CompletedNCT02720107Phase 4Results posted
• A TSEC for Symptom Management in Menopausal Women With Multiple SclerosisCompletedNCT02710214Phase 2Results posted
• Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)CompletedNCT02688985Phase 3Results posted
• Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple SclerosisCompletedNCT02687919Not applicableResults posted
• Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDYTerminatedNCT02665221Phase 4Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2TerminatedNCT02660359Phase 3Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1TerminatedNCT02660138Phase 3Results posted
• Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple SclerosisCompletedNCT02651545Results posted
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)CompletedNCT02637856Phase 3Results posted
• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1CompletedNCT02634307Phase 3Results posted
• Treating Anorectal Dysfunction in MSTerminatedNCT02609607Phase 2Results posted
• Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MSCompletedNCT02606604Not applicableResults posted
• Plegridy Satisfaction Study in ParticipantsCompletedNCT02587065Phase 4Results posted
• A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple SclerosisCompletedNCT02576717Phase 3Results posted
• Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT02555215Phase 3Results posted
• A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple SclerosisCompletedNCT02545868Phase 3Results posted
• CPAP to Treat Cognitive Dysfunction in MSCompletedNCT02544373Not applicableResults posted
• tDCS and Cognition in Adults With Multiple Sclerosis or EncephalitisCompletedNCT02538094Not applicableResults posted
• Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).CompletedNCT02525874Phase 3Results posted
• Wearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple SclerosisCompletedNCT02519244Not applicableResults posted
• Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®CompletedNCT02499900Phase 4Results posted
• Augmenting Cerebral Blood Flow to Treat Established Multiple SclerosisTerminatedNCT02466074Phase 2Results posted
• Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MSTerminatedNCT02446886Phase 4Results posted
• BG00012 and Delay of Disability Progression in Secondary Progressive Multiple SclerosisTerminatedNCT02430532Phase 3Results posted
• Tecfidera Slow-Titration StudyTerminatedNCT02428231Phase 3Results posted
• Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple SclerosisCompletedNCT02425644Phase 3Results posted
• Study of Montelukast on Gastrointestinal Tolerability in Patients With Relapsing Forms of Multiple Sclerosis Receiving TecfideraCompletedNCT02410278Phase 4Results posted
• Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMSCompletedNCT02410200Phase 2Results posted
• Study and Treatment of Visual Dysfunction and Motor Fatigue in Multiple SclerosisCompletedNCT02391961Phase 2Results posted
• Physical Telerehabilitation in Veterans With Multiple SclerosisCompletedNCT02346734Not applicableResults posted
• Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.TerminatedNCT02343159Phase 4Results posted
• Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsTerminatedNCT02342704Phase 4Results posted
• Theory Based Intervention Program to Support Physical Activity for Individuals With Multiple Sclerosis: a Case SeriesCompletedNCT02335450Not applicableResults posted
• ACTH for Fatigue in Multiple Sclerosis PatientsCompletedNCT02315872Phase 3Results posted
• Long-term Follow-up of Fingolimod Phase II Study PatientsCompletedNCT02307838Phase 4Results posted

← Multiple Sclerosis overview